Related Experiment Videos
Fibrinogen and coronary risk
1Department of Internal Medicine II, Cardiology, University of Ulm Medical Center, Robert-Koch-Str 8, D-89081, Ulm, Germany.
Current Cardiology Reports
|September 12, 2000
Summary
Fibrinogen is a key marker for coronary risk, linked to atherosclerosis and heart disease. While its exact role is still debated, elevated fibrinogen levels indicate increased cardiovascular risk.
Area of Science:
- Cardiovascular Science
- Hematology
- Epidemiology
Background:
- Fibrinogen is widely accepted as a significant independent risk factor for coronary heart disease.
- Numerous prospective studies and clinical observations support the link between fibrinogen and cardiovascular risk.
- The precise pathophysiological mechanisms underlying elevated fibrinogen in atherosclerosis remain incompletely understood.
Purpose of the Study:
- To explore the multifaceted roles of fibrinogen in atherothrombogenesis.
- To elucidate the mechanisms by which elevated fibrinogen contributes to coronary risk.
- To assess the current understanding of fibrinogen's causal involvement in cardiovascular disease.
Main Methods:
- Review of prospective epidemiological studies.
- Analysis of clinical observations.
- Examination of cellular and molecular mechanisms involved in fibrinogen's role in atherosclerosis.
Main Results:
- Fibrinogen acts as a substrate for thrombin, crucial in coagulation.
- It plays a role in platelet aggregation and endothelial function.
- Elevated fibrinogen is associated with smooth muscle cell proliferation and modulates plasminogen binding.
Conclusions:
- Fibrinogen is a major acute phase protein and an important marker of coronary risk.
- Its causal role in atherothrombogenesis requires further investigation.
- Understanding fibrinogen's mechanisms is key to managing cardiovascular risk.